Volume 3, Number 2—June 1997
Perspective
The Economic Impact of a Bioterrorist Attack: Are Prevention and Postattack Intervention Programs Justifiable?
Table 1
Anthrax |
Tularemia |
Brucellosis |
||||
---|---|---|---|---|---|---|
Base | Upper | Base | Upper | Base | Upper | |
Hospitalized patient | ||||||
Days in hospital | 7 | 7 | 10 | 10 | 7 | 7 |
Cost per day ($)a | 556 | 669 | 556 | 669 | 556 | 669 |
Lost productivity ($/day) | 65 | 65 | 65 | 65 | 65 | 65 |
Follow-up OPVs (no.) | 2 | 2 | 2 | 2 | 7 | 7 |
Cost 1st OPV ($) | 28 | 44 | 28 | 44 | 28 | 44 |
Cost other OPVs, ea. ($) | 13 | 24 | 13 | 24 | 13 | 24 |
OPV laboratory ($)b,c | 87 | 174 | 87 | 174 | 131 | 261 |
OPV x-rays costs ($)d | 66 | 66 | 0 | 0 | 0 | 0 |
Lost productivity ($/OPV)e | 16 | 16 | 16 | 16 | 16 | 16 |
Total costs ($) | 4,541 | 5,380 | 6,338 | 7,582 | 4,584 | 5,587 |
Avg. costs/day ($/day) | 649 | 769 | 634 | 758 | 655 | 798 |
% increase: Base to upper estimate | 18 | 20 | 22 | |||
Nonhospitalized patient | ||||||
Number of OPVs | 7 | 7 | 12 | 12 | 14 | 14 |
Cost 1st OPV ($) | 28 | 44 | 28 | 44 | 28 | 44 |
Cost other OPVs, ea. ($) | 13 | 24 | 13 | 24 | 13 | 24 |
Lost productivity ($/OPV)e | 16 | 16 | 16 | 16 | 16 | 16 |
Laboratory costs ($)b,f | 131 | 174 | 261 | 522 | 261 | 522 |
X-ray costs ($)d | 66 | 66 | 66 | 66 | 66 | 66 |
Drugs usedg | D | C | D+G | D+G | D+R | D+R+G |
Cost of drugs ($) | 6 | 181 | 29 | 29 | 220 | 246 |
Total costs ($) | 422 | 810 | 722 | 1,120 | 972 | 1,418 |
Avg. costs/day ($/day) | 60 | 116 | 60 | 93 | 69 | 101 |
% increase: Base to upper estimate | 93 | 55 | 46 |
Notes: All costs rounded to the nearest whole dollar.
aHospital costs assumed to include all costs such as drugs, laboratory tests, and x-rays.
bLaboratory tests consists of general health panel (CPT code 80050) and an antigen or antibody test (modeled on the cost of a Streptococcus screen, CPT code 86588).
cFollow-up OPVs for hospitalized patients included two laboratory test sets for anthrax and tularemia patients and three laboratory test sets for brucellosis patients.
dX-ray costs (CPT code 71021), included two sets taken at different OPVs.
eProductivity lost due to an OPV was assumed to be one-quarter of an unspecified day's value.
fFor OPVs of nonhospitalized patients, one set of laboratory tests is assumed for every two visits.
gDrugs used: D = doxycycline; C = ciprofloxacin; R = rifampin.
Sources: See text for explanation of sources of cost estimates.